Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-05 |
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0003 |
mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0007 |
mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.001 |
mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.002 |
mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.005 |